guest ::
| Home > In process > Hypothalamic atrophy in progressive supranuclear palsy, assessed by convolutional neural network-based automatic segmentation. |
| Home > In process > Hypothalamic atrophy in progressive supranuclear palsy, assessed by convolutional neural network-based automatic segmentation. |
| Journal Article | DZNE-2026-00269 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Steinkopff
[Darmstadt]
This record in other databases: 
Please use a persistent id in citations: doi:10.1007/s00415-026-13718-z
Abstract: The hypothalamus as one of the core structures in metabolic control is increasingly recognized to be morphologically altered in various neurodegenerative diseases.The purpose of this study was to quantitatively investigate the hypothalamic volumes in patients with progressive supranuclear palsy (PSP) and to compare them with controls and Parkinson disease (PD) patients.An automatic hypothalamic volume quantification method based on the use of convolutional neural networks (CNN) of U-Net architecture was applied to the automatic segmentation of the hypothalamus and intracranial volumes (ICV). This CNN-based volumetric analysis was performed in high resolution T1 weighted MRI in two PSP cohorts: cohort A with 78 PSP patients and 63 controls was recorded at 3.0 T at multiple sites; the single site cohort B consisted of 66 PSP patients, 66 PD patients, and 44 controls, recorded at 1.5 T.In cohort A, significant hypothalamic volume reduction was observed in PSP (774 ± 83 mm3) when compared to controls (817 ± 74 mm3). In cohort B, this result of significant hypothalamic volume reduction was confirmed in PSP (745 ± 102 mm3) when compared to controls (831 ± 81 mm3); no significant hypothalamic volume reduction was observed in PD (797 ± 98 mm3), in support of previous studies.The CNN-based hypothalamus volume quantification study demonstrated significantly reduced hypothalamus volumes in PSP patients compared to controls and PD, respectively; future studies will address the metabolic profiles of PSP as potential functional correlates.
Keyword(s): Humans (MeSH) ; Supranuclear Palsy, Progressive: diagnostic imaging (MeSH) ; Supranuclear Palsy, Progressive: pathology (MeSH) ; Supranuclear Palsy, Progressive: complications (MeSH) ; Male (MeSH) ; Female (MeSH) ; Aged (MeSH) ; Hypothalamus: pathology (MeSH) ; Hypothalamus: diagnostic imaging (MeSH) ; Magnetic Resonance Imaging: methods (MeSH) ; Middle Aged (MeSH) ; Neural Networks, Computer (MeSH) ; Atrophy: diagnostic imaging (MeSH) ; Atrophy: pathology (MeSH) ; Parkinson Disease: diagnostic imaging (MeSH) ; Parkinson Disease: pathology (MeSH) ; Cohort Studies (MeSH) ; Image Processing, Computer-Assisted: methods (MeSH) ; Convolutional Neural Networks (MeSH) ; Hypothalamus ; Magnetic resonance imaging ; Metabolism ; Neural networks ; Progressive supranuclear palsy ; Volumetry
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz
; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF
PDF (PDFA)